Somatic Pairing of Chromosome 19 in Renal Oncocytoma Is Associated with Deregulated ELGN2-Mediated Oxygen-Sensing Response
2008

Somatic Pairing of Chromosome 19 in Renal Oncocytoma and Its Effects on Oxygen-Sensing

Sample size: 20 publication 15 minutes Evidence: moderate

Author Information

Author(s): Koeman Julie M., Russell Ryan C., Tan Min-Han, Petillo David, Westphal Michael, Koelzer Katherine, Metcalf Julie L., Zhang Zhongfa, Matsuda Daisuke, Dykema Karl J., Houseman Heather L., Kort Eric J., Furge Laura L., Kahnoski Richard J., Richard Stéphane, Vieillefond Annick, Swiatek Pamela J., Teh Bin Tean, Ohh Michael, Furge Kyle A.

Primary Institution: Van Andel Research Institute

Hypothesis

The somatic pairing of chromosome 19 in renal oncocytoma is associated with deregulated EGLN2-mediated oxygen-sensing response.

Conclusion

The study found that somatic pairing of chromosome 19 leads to significant changes in gene expression, particularly affecting the EGLN2 gene, which is crucial for oxygen sensing in renal oncocytoma.

Supporting Evidence

  • Somatic pairing of chromosome 19 was identified as a recurrent chromosomal abnormality in renal oncocytoma.
  • Overexpression of EGLN2 was linked to the deregulation of several hypoxia-inducible genes.
  • Transcriptional changes associated with somatic pairing mimic those seen in DNA amplification.
  • Defects in the oxygen-sensing network were directly implicated in the biology of renal oncocytoma.

Takeaway

This study shows that a specific chromosome pairing in kidney tumors can mess up how cells respond to oxygen, which is important for their survival.

Methodology

Gene expression profiling and comparative genomic microarray analysis were used to identify chromosomal abnormalities and gene expression changes in renal oncocytoma and chromophobe RCC samples.

Limitations

The study primarily focused on a limited number of tumor samples, which may not represent all cases of renal oncocytoma.

Participant Demographics

The study included samples from both male and female patients, with a focus on renal oncocytoma and chromophobe RCC.

Statistical Information

P-Value

p<0.01

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1371/journal.pgen.1000176

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication